News and Views


Nature Medicine 14, 118 - 119 (2008)
doi:10.1038/nm0208-118

Safer, longer-lasting regulatory T cells with bold beta-catenin

Jeffrey A Bluestone1 & Matthias Hebrok1

  1. Jeffrey A. Bluestone and Matthias Hebrok are in the University of California–San Francisco Diabetes Center and Department of Medicine, University of California–San Francisco, Health Sciences West 1114, Box 0540, 513 Parnassus Avenue, San Francisco, California 94143, USA. e-mail: jbluest@diabetes.ucsf.edu


Expressing a stabilized form of beta-catenin extends the lifespan of regulatory T cells— one goal of therapies that take advantage of these cells (pages 162–169).

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

naturejobs

natureproducts


ADVERTISEMENT